RxDoctor Payments Data

Jessica Clement

Hematology & Oncology · Hartford, CTNPI 1487713913

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $108 of the $154 with a category attached, or 70.1%. E.r. Squibb & Sons, L.L.C. accounts for 70.1% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for hematology & oncology clinicians in CT, where the typical reported total is $1,376.

$154in general payments, 2019–2025

Across 5 payments — averaging $30.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$108
  • Pfizer$34
  • Seagen Inc.$12
$886,745in research payments, 2019–2025

Across 22 payments — averaging $40,307 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$853K
  • Genentech, Inc.$22K
  • AstraZeneca$7K
  • Incyte Corporation$5K

What the payments were for

  • Food & beverage$10870%
  • Education$4630%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.1$108
Pfizer3$34
Seagen Inc.1$12

How this compares

$154 in reported general payments places this provider in the 25th percentile of 163 hematology & oncology providers in Connecticut.

See all hematology & oncology providers in Connecticut

Other hematology & oncology in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →